May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Prospective Surveillance of Visual Function in Patients With Ocular Melanoma Undergoing Iodine-125 Plaque Brachytherapy
Author Affiliations & Notes
  • S. Oliver
    Ophthalmology, Jules Stein Eye Institute, Los Angeles, California
  • T. A. Young
    Ophthalmology, Jules Stein Eye Institute, Los Angeles, California
  • M. Chun
    Ophthalmology, Jules Stein Eye Institute, Los Angeles, California
  • J. Moral
    Ophthalmology, Jules Stein Eye Institute, Los Angeles, California
  • B. R. Straatsma
    Ophthalmology, Jules Stein Eye Institute, Los Angeles, California
  • Footnotes
    Commercial Relationships S. Oliver, None; T.A. Young, None; M. Chun, None; J. Moral, None; B.R. Straatsma, None.
  • Footnotes
    Support Retina Division, Jules Stein Eye Institute
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 5262. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Oliver, T. A. Young, M. Chun, J. Moral, B. R. Straatsma; Prospective Surveillance of Visual Function in Patients With Ocular Melanoma Undergoing Iodine-125 Plaque Brachytherapy. Invest. Ophthalmol. Vis. Sci. 2007;48(13):5262.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: To report the protocol for visual function assessment and the baseline enrollment characteristics in a prospective cohort study of patients with choroidal melanoma undergoing Iodine-125 plaque radiotherapy.

Methods:: In a prospective study of patients with choroidal melanoma enrolled between March 2005 and November 2006, ophthalmic evaluation was performed prior to Iodine-125 plaque brachytherapy and baseline findings are reported.

Results:: The protocol for baseline assessment includes ophthalmic history, standardized visual acuity, contrast sensitivity, and color vision assessment, comprehensive ophthalmic examination, fundus photography, fluorescein angiography, and ultrasonography. Thirty patients (mean age 61 ± 12) were enrolled with a mean tumor height of 4.01 mm. Tumor location was macular in 7 patients, posterior to the equator in 15, equatorial in 5, and anterior to the equator in 3. Mean ETDRS acuity was 47 letters, mean Pelli-Robson contrast sensitivity score was 29, and mean HRR score was 12. Visual function was reassessed at 12 month intervals.

Conclusions:: Radiation maculopathy, papillopathy, and proliferative retinopathy are known complications of Iodine-125 plaque brachytherapy for choroidal melanoma. Prospective assessment of visual function will allow better understanding of the ocular effects of radiation therapy.

Keywords: melanoma • visual acuity • radiation therapy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×